GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Oncoclinicas Do Brasil Servicos Medicos SA (BSP:ONCO3) » Definitions » Return-on-Tangible-Asset

Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) Return-on-Tangible-Asset : 0.75% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Oncoclinicas Do Brasil Servicos Medicos Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Oncoclinicas Do Brasil Servicos Medicos's annualized Net Income for the quarter that ended in Mar. 2024 was R$38 Mil. Oncoclinicas Do Brasil Servicos Medicos's average total tangible assets for the quarter that ended in Mar. 2024 was R$5,146 Mil. Therefore, Oncoclinicas Do Brasil Servicos Medicos's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 was 0.75%.

The historical rank and industry rank for Oncoclinicas Do Brasil Servicos Medicos's Return-on-Tangible-Asset or its related term are showing as below:

BSP:ONCO3' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -8.56   Med: -1.62   Max: 4.81
Current: 4.47

During the past 6 years, Oncoclinicas Do Brasil Servicos Medicos's highest Return-on-Tangible-Asset was 4.81%. The lowest was -8.56%. And the median was -1.62%.

BSP:ONCO3's Return-on-Tangible-Asset is ranked better than
64.19% of 673 companies
in the Healthcare Providers & Services industry
Industry Median: 1.6 vs BSP:ONCO3: 4.47

Oncoclinicas Do Brasil Servicos Medicos Return-on-Tangible-Asset Historical Data

The historical data trend for Oncoclinicas Do Brasil Servicos Medicos's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncoclinicas Do Brasil Servicos Medicos Return-on-Tangible-Asset Chart

Oncoclinicas Do Brasil Servicos Medicos Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Asset
Get a 7-Day Free Trial -1.67 -8.56 -1.57 1.14 4.81

Oncoclinicas Do Brasil Servicos Medicos Quarterly Data
Dec18 Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.07 1.92 9.32 6.34 0.75

Competitive Comparison of Oncoclinicas Do Brasil Servicos Medicos's Return-on-Tangible-Asset

For the Medical Care Facilities subindustry, Oncoclinicas Do Brasil Servicos Medicos's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oncoclinicas Do Brasil Servicos Medicos's Return-on-Tangible-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Oncoclinicas Do Brasil Servicos Medicos's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Oncoclinicas Do Brasil Servicos Medicos's Return-on-Tangible-Asset falls into.



Oncoclinicas Do Brasil Servicos Medicos Return-on-Tangible-Asset Calculation

Oncoclinicas Do Brasil Servicos Medicos's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=223.618/( (4305.315+4990.55)/ 2 )
=223.618/4647.9325
=4.81 %

Oncoclinicas Do Brasil Servicos Medicos's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=38.368/( (4990.55+5302.084)/ 2 )
=38.368/5146.317
=0.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2024) net income data.


Oncoclinicas Do Brasil Servicos Medicos  (BSP:ONCO3) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Oncoclinicas Do Brasil Servicos Medicos Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Oncoclinicas Do Brasil Servicos Medicos's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Presidente Juscelino Kubitschek, No. 510, 2nd Floor, Vila Nova Conceicao, Sao Paulo, SP, BRA, 04543-906
Oncoclinicas Do Brasil Servicos Medicos SA is engaged in the management and administration of oncological services. It has specialists in the areas of oncology, radiotherapy, hematology and bone marrow transplantation, complementary care.

Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) Headlines

No Headlines